The profile of comorbities in patients with COVID-19 in the municipality of Parnaíba-PI
DOI:
https://doi.org/10.33448/rsd-v12i7.42519Keywords:
Coronavirus; Comorbidity; Epidemiology; Age groups.Abstract
COVID-19 can affect individuals of any age, but usually the most serious conditions are related to people over 60 years of age and/or with comorbidities, such as systemic arterial hypertension, diabetes and obesity, because in addition to these conditions they lead to structural changes, the Treatment itself may predispose individuals to a greater risk of infection. The objective of the study is to outline the clinical-epidemiological profile of patients with a confirmed case of COVID-19 who had at least one comorbidity in the municipality of Parnaíba, Piauí. This is an epidemiological study carried out through the analysis of data extracted from the flu syndrome investigation form, after applying the inclusion and exclusion criteria of research participants, the study sample was completed in 684 patients. Most were female (61.25%), with a predominance between 18 and 30 years old (29.58%), followed by 31 to 45 years old (27.65%). Of these patients, 79.25% evolved to cure and 8.06% to death. Regarding deaths, there was a predominance of deaths in males, over 60 years old and with at least one comorbidity, the conditions most related to death cardiovascular disease, diabetes and respiratory disease. The presence of comorbidity is an unfavorable prognosis, namely: severe acute respiratory syndrome (SARI), admission to the Intensive Care Unit (ICU), need for invasive mechanical ventilation, cardiac abnormalities and death. A large number of underreported or incorrectly registered cases were observed, which may hinder the epidemiological characterization and disease control strategies.
References
Antonio, M. V. N., Imperador, C. H. L., Espreafico Júnior, C. R., Chin, C. M. & Bosquesi, P. L. (2020) Tempestade de citocinas na COVID-19. Journal of Medicine Ulakes. 1. 31-40.
Barbosa, M. L. C. S., Silva, M. E. W. B., Silva, J. E. C. F., Silva, D. L., Rafael, K. J. G., Lima Filho, C. A., Silva, L. R. A., Silva, B. M. M., Amorim, E. R. L. & Soares, l. L. (2021). Complicações obstétricas e perinatais durante a pandemia do COVID-19. Research, Society and Development. 10(14).
Banerjee M., Gupta, S., Sharma, P., Shekhawat, J. & Gauba, k. (2020). Obesity and COVID-19: a fatal aliance. Indian J Clin Biochem. 35(4). 410-417.
Beltrão, R. P. L., Silva, A. C. B., Mouta, A. A. M., Beltrão, B. C. B., Couto, R. N., Oliveira, J. E. N., Lopes, S. D. L., Lima, D. A., Costa, C. P. M., Rigamonte, N. G. S., Beltrão, C. M. F., Silva, D. F. B., Bezerra, D. M., Beltrão, I. T. & Almendra Neto, O. L. (2020). Análise das altas realizadas pela equipe de monitoramento remoto de COVID-19 em Cidade do Piauí. Research, Society and development. 9(8).
Carvalho, F. R. S., Gobbi, L. C., Casotti, G. C., Lyra, M. E. D., Tiussi, L. M., Caetano, A. J. F., Cavalari, A. L. C., Pinheiro, M. I. L. & Carrijo-Carvalho, L. C. (2020). Fisiopatologia do COVID-19 repercussões sistêmicas. UNESC em revista. 2.
Costa, I. B. S. S., Bittar, C. S., Rizk, S. I., Araújo Filho, A. E., Santos, K. A. Q., Machado, T. I. V., Andrade, F. T. A., González, T. B., Arêvalo, A. N. G., Almeida, J. P., Bacal, F., Oliveira, G. M. M., Lacerda, M. V. G., Barberato, S. H., Chagas, A. C. P., Rochitte, C. E., Ramires, J. A. F., Kalil Filho, R. & Hajjar, L. A. (2020). O Coração e a COVID-19: O que o Cardiologista Precisa Saber. Arq Bras Cardiol., 114(5).
Ejaz, H., Alshani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z. & Younas, S. (2020). COVID-19 and comorbidities: deleterious impact on infected patient. Journal of infection and public health. 13(2).
Fang, X., Li, S., Yu, H., Wang, Y., Chen, Z., Li, Y., Cheng, L., Li, W., Jia, H. & Ma, X. (2020). Epidemiological, comorbidity factores with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. 13(12).
Favretto, I. C., Jaques, H. S., Oliveira, H. T., Ferreto, L. E. D. & Wendt, G. W. (2021). Fatores de risco associados ao acometimento pela COVID-19 em pacientes oncológicos: uma revisão sistemática. R. Saúde Pública. 4(2).
Galvão, M. H. R. & Roncalli, A. G. (2020). Fatores associados a maior risco de ocorrência de óbito por COVID-19: análise de sobrevivência com base em casos confirmados. Rev Bras Epidemiol. 23(n. espE200106).
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., Iotti, G., Latronico, N., Lorini, L., Merler, S., Natalini, G., Piatti, A., Ranieri, M. V., Scandroglio, A. M., Storri, E., Cecconi, M. & Pesenti, A. (2020). COVID-19 Lombardy ICU Network. Características e desfechos da linha de base de 1591 pacientes infectados com SARS-CoV-2 admitidos em UTIs da região da Lombardia, Itália. O JAMA. 323.
Goswami, G. G., Mahapatro, M., Ali, A. R. M. M. & Rahman, R. (2021). Do old age and comorbidity via non-communicable diseases matter for COVID-19 mortality? A pat analysis. Front Public Health. 16(9).
Kumar, M. & Thakur, A. K. (2020). Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurological Sciences, 41(12).
Leonardi, M., Padavoni, A., Mcarthur, J. C. (2020). Neurological manifestations associated with COVID 19: a review and a call for action. Journal of neurology. 267(6).
Marinho, F. P., Loyola, I. S., Monteiro, I. O. F., Castro, T. M., Carvalho, M. G. S., Silvério, A. C. P. & Santos, G. B. (2021). Inter-relação entre COVID-19 e diabetes mellitus: uma revisão sistemática. Research, society and development. 10(2).
Massarva, T. (2021). Clinical outcomes of COVID-19 amongs HIV patients: a systematic literature review. Epidemiol Health. 43(E2021036).
Santos, L. A. O., Mendonça, G. S., Silva, V. A., Beltrão, R. P. L. & Pereira Júnior, J. L. (2021) Perfil epidemiológico das infecções por COVID-19 no município de Parnaíba-PI. Research, Society and development. 10(15).
Soares, A. L. B., Melchiadesl. B., Rezende, R. R. M. M., Dias, R. C. M. A., Matias, C. A., Lima, C. A., Bruzadin, M. L., Morais, L. A. L., Ferneda, R. C. & Mioto, T. S. 2021. Complicações da COVID-19 na gravidez. Brazilian Journal of developmentet. 7(9).
Ozceylan, G. & Altuntas, S. B. (2022). Relationship between initial symptons and prognosis of patients with COVID-19. Aténcion primaria. 54(1). Página eletrônica.
Parker, J. J., Octaria, R., Smith, M. D., Chao, S. J., Davis, M. B., Goodson, C., Warkentin, J., Werner, D. & Fill, M. M. A. (2021). Characteristics, comorbidities, and Data Gaps for coronavirus disease death, Tennessee, USA. Emerg Infect Dis. 27(10). 2521 – 2528.
Popkin, B. M., Du, S., Green, W. D., Breck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N. & Shekar, M. (2020). Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships.Wiley – Obesity reviews. 21.
Prado, M. F., Antunes, B. B. P., Bastos, L. S. L., Peres, I. T., Silva, A. A. B., Dantas, L. F., Baião, F. A., Maçaira, P., Hamacher, S. & Bozza, F. A. (2020). Análise da subnotificação de COVID-19 no Brasil. Rev Bras Terapia Intensiva. 32(2). 224-228.
Pecly, I. M. D., Azevedo, R. B., Muxfeldt, E. S., Botelho, B. G., Diniz, P. H. P., Silva, R. & Rodrigues, C. I. S. (2021). COVID-19 e doença renal crônica: uma revisão abrangente. Braz. J. Nephrolog. 43(3).
Pérez-López FR, Tajada M, Savirón-Cornudella R, Sánchez-Prieto M, Chedraui P. & Terán E. (2020). Coronavirus disease 2019 and gender-related mortality in European countries: a meta-analysis. Maturitas. 141.
Santana, V. V. R. S., Oliveira, K. C. P. N., Mendonça, K. S., Silva, D. T. & Dantas, H. L. L. (2020). Fatores de risco para o agravamento da COVID-19 em indivíduos jovens. Emferm Foco. 11(esp 2).
Wark, P. A. B., Pathinayake, P. S., Kaiko, G., Nichol, K., Ali, A., Chen, L., Sutanto, E. N., Garratt, L. W., Sohal, S. S., Lu, W., Eapen, M. S., Oldmeadow, C., Bartlett, N., Reid, A., Veerati, P., Hsu, A. C., Looi, K., Iosifidis, T., Stick, S. M., Hansbro, P. M. & Kicic, A. (2021). ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma. Respirology. 26(5).
Yang, C. L., Zeng, Q. K. Y. K., Jiang, M., Fan, H. R. & Zhang, Z. M. (2020). Coronavirus disease 2019: a clinical review. European Review for Medical and Pharmacological Sciences. 24(8).
Zeng, F., Dai, C., Cai, P., Wang, J., Xu, L., Li, J., Hu, G., Wang, Z., Zheng, F. & Wang, L. (2020). A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol. 92.
Zhou, Y., yang, Q., Chi, J., Dong, B., Ly, W., Shen, L. & Wang, Y. (2020a) Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. International jornal of infectious diseases. 99.
Zhou, R., Li, F., Chen, F., Liu, H., Zheng, J., Lei, C. & Wu, X. (2020b). Viral dynamics in asymptomatic patients with COVID-19. International Journal of Infectious Diseases. 96.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Samuel Davi Sousa Lopes; Lucas Emanuel Ribeiro Vasconcelos; Alba Angélica Nunes Mouta; Davi Sérgio dos Santos Pacífico; Marília Ursulino Barbosa; Larissa Oliveira Batista; Ilvanete Tavares Beltrão; Demétrio Félix Beltrão da Silva; Renata Paula Lima Beltrão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
